The pathology of coronavirus disease 2019 (COVID-19) is exacerbated by the progression
of thrombosis, and disseminated intravascular coagulation (DIC), and cytokine storms. The …

Abstract Coronavirus disease 2019 (Covid-19) is a worldwide infectious disease caused by
severe acute respiratory coronavirus 2 (SARS-CoV-2). In severe SARS-CoV-2 infection …

In December 2019, a novel coronavirus, named Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) or (2019-nCoV) with unknown origin spread in Hubei province …

Introduction Venous thromboembolism (VTE) has been observed as a frequent complication
in patients with severe novel coronavirus disease 2019 (COVID-19) infection requiring …

Background The novel coronavirus SARS-CoV-2, responsible for the 2019–2020 global
(COVID-19) pandemic, is a respiratory virus associated with the development of …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is responsible of
variable clinical manifestations, ranging from no symptoms to severe pneumonia with acute …

The rapid worldwide spread of the COVID-19 pandemic, caused by the newly emerged
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in tens of …

At the beginning of 2020, the national health system and medical communities are faced
with unprecedented public health challenges. A novel strain of coronavirus, later identified …

Background Coagulopathy and thromboembolic events are among the complications of
Corona Virus disease 2019 (COVID-19). Abnormal coagulation parameters in COVID-19 …

The newly emerged coronavirus (severe acute respiratory syndrome coronavirus 2 SARS-
CoV-2) and the disease that it causes coronavirus disease 2019 (COVID-19) have changed …